This text is a result of machine translation.
Stepping Into 2023 | Ten Investors' Insights into Opportunities and Challenges for Chinese
Many years from now, this generation will have aged and retired. We may imagine an elderly retiree sitting on a wheelchair pushed by the ‘bicentennial man’ or similar robot helper, admiring a holographic projection of the California Sunset, and sipping from a cup of biochemical coffee which prevents aging.
Feb 14, 2023 12:23 PM
We-Linking Raised Over CNY 10 Mn in Angel Round
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A
ZD Medtech Raised Over CNY 100 Mn in Series B
Smart Powered Bionic Prosthetic Star BionicM Nets Over CNY 10 Mn
Medical Technology Company MacroLux Nets Nearly CNY 100 Mn in Series A
ForLong Biotech Nets Over CNY 100 Mn in Series A
CytoCan Corp. Nets CNY 10 Mn in Seed Round
Fine Vision Completes Angel Financing Round Worth Nearly CNY 50 Mn
SHEIN's valuation evaporates $36 billion, challenge from Chinese e-commerce platform Temu
On the one hand, the rapid rise of competitors has led to such a result, but on the other hand, it has also revealed a lot of problems for SHEIN itself.
Mar 12, 2023 10:53 AM
Levostar Completes Pre-A Financing Round to Further Invest in CGT
Pharmaceutical business concept stocks quickly rose the first pharmaceutical trading limit
Yuntianhua: the shareholder completed the reduction of 2% of the shares with the investment of Yuntianhua
Yifeng: Xiao Zaixiang, the Vice President, Intends to Sell Shares